Universe · entity
Casdin Capital, LLC
Institutional manager (13F) · CIK 1534261
13F holdings · as of 2026-03-31 · top 40 · reported portfolio $1.3B
| # | Issuer | Value | Shares |
|---|---|---|---|
| 1 | REVOLUTION MEDICINES INC | $251M | 2,577,333 |
| 2 | GENEDX HOLDINGS CORP | $193M | 3,007,164 |
| 3 | RELAY THERAPEUTICS INC | $143M | 14,418,574 |
| 4 | BIOLIFE SOLUTIONS INC | $114M | 5,957,165 |
| 5 | STANDARD BIOTOOLS INC | $82M | 88,783,856 |
| 6 | ILLUMINA INC | $65M | 530,000 |
| 7 | STRUCTURE THERAPEUTICS INC | $57M | 1,175,000 |
| 8 | 10X GENOMICS INC | $48M | 2,275,000 |
| 9 | DENALI THERAPEUTICS INC | $35M | 1,840,000 |
| 10 | BEAM THERAPEUTICS INC | $32M | 1,350,000 |
| 11 | GUARDANT HEALTH INC | $29M | 315,000 |
| 12 | NEUROGENE INC | $29M | 1,420,361 |
| 13 | ALNYLAM PHARMACEUTICALS INC | $25M | 75,000 |
| 14 | MAZE THERAPEUTICS INC | $23M | 758,857 |
| 15 | SCHOLAR ROCK HLDG CORP | $17M | 350,000 |
| 16 | AGOMAB THERAPEUTICS NV | $16M | 1,550,000 |
| 17 | HIMS & HERS HEALTH INC | $15M | 700,000 |
| 18 | TAYSHA GENE THERAPIES INC | $15M | 3,250,000 |
| 19 | QIAGEN NV | $14M | 360,000 |
| 20 | TEMPUS AI INC | $13M | 294,127 |
| 21 | SEPTERNA INC | $13M | 553,268 |
| 22 | GRAIL INC | $12M | 230,000 |
| 23 | PRIME MEDICINE INC | $11M | 3,167,175 |
| 24 | PERSONALIS INC | $10M | 1,600,000 |
| 25 | QUEST DIAGNOSTICS INC | $10M | 50,000 |
| 26 | VERACYTE INC | $9M | 276,308 |
| 27 | MOONLAKE IMMUNOTHERAPEUTICS | $8M | 450,000 |
| 28 | INTELLIA THERAPEUTICS INC | $5M | 355,000 |
| 29 | DISC MEDICINE INC | $4M | 65,000 |
| 30 | MODERNA INC | $4M | 75,000 |
| 31 | ADLAI NORTYE LTD | $4M | 538,461 |
| 32 | MONTE ROSA THERAPEUTICS INC | $3M | 186,014 |
| 33 | ABSCI CORPORATION | $3M | 973,260 |
| 34 | CENTURY THERAPEUTICS INC | $3M | 1,228,190 |
| 35 | BRIDGEBIO ONCOLOGY THERAPEUT | $3M | 282,312 |
| 36 | CONTINEUM THERAPEUTICS INC | $2M | 148,333 |
| 37 | PACIFIC BIOSCIENCES CALIF IN | $955k | 723,767 |
| 38 | RECURSION PHARMACEUTICALS IN | $508k | 165,323 |
| 39 | TENAYA THERAPEUTICS INC | $251k | 361,969 |
| 40 | GINKGO BIOWORKS HOLDINGS INC | $224k | 36,493 |
Source: sec_edgar_13f · public regulatory · retrieved 2026-06-29. Public SEC data; no contact information.